Keywords: PCNA; posterior cutaneous nerve of the arm; PCNF; posterior cutaneous nerve of the forearm; PRCA; posterior radial collateral artery; ALT; anterolateral thigh; BMI; body mass index; SMIF; submental island flap; SCAIF; supraclavicular flap; PMF; pectoralis
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: AAA; acquired aplastic anemia; IBMF; inherited bone marrow failure; IST; immunosuppressive therapy; CSA; cyclosporine A; ATG; antithymocyte globulin; CR; complete response; PR; partial response; TA; telomerase activity; TRAP; Telomeric Repeat Amplificatio
Keywords: pure red cell aplasia; whole exome sequencing; autoinflammatory diseases; vasculitis; ADA; Adenosine deaminase; WES; Whole exome sequencing; CECR1; Cat eye syndrome chromosome region candidate 1; PRCA; Pure red cell aplasia; DBA; Diamond-Blackfan anemia
Keywords: ACI; anemia of chronic inflammation; AD[H]D; attention deficit[/hyperactivity] disorder; ASD; autism spectrum disorder; BMS; burning mouth syndrome; BPAD; bipolar affective disorder; CCS; Cronkhite-Canada syndrome; CFS; chronic fatigue syndrome; CGRP; cal
Keywords: TPP; therapeutic protein product; ADA; anti-drug antibody; mAb; monoclonal antibody; RA; rheumatoid arthritis; MS; multiple sclerosis; IBD; inflammatory bowel disease; NAb; neutralizing ADA; non-NAb; non-neutralizing ADA; PK; pharmacokinetics; PRCA; pure
Development of an anti-EPO antibody detection kit based on lab-on-a-chip and bridging antibody technologies
Keywords: EPO; Erythropoietin; ADA; Anti-drug antibody; PRCA; Pure red cell aplasia; ELISA; Enzyme-linked immunosorbent assay; SPR; Surface plasmon resonance; Ab; antibody; FL; fluorescence; T/R ratio; Test/reference ratio; POC; Point of care;
Optimization infusions conditions for improving phenolic content and antioxidant activity in Sideritis scardica tea using response surface methodology
Keywords: AP; aerial parts; CA; caffeic acid; CCD; central-composite design; CLA; chlorogenic acid; CNA; cinnamic acid; FA; ferulic acid; F; flowers; GA; gallic acid; L; leaves; pCA; p-coumaric acid; PRCA; protocatechuic acid; RSA-DPPH; DPPH radical scavenging acti
Transitioning from first- to second-generation biosimilars: An appraisal of regulatory and post-marketing challenges
Keywords: ACR; American College of Rheumatology; ADAb; anti-drug antibody; ADCC; antibody-dependent cell-mediated cytotoxicity; AIFA; Italian Medicines Agency; CDC; complement-dependent cytotoxicity; CHMP; Committee for Medicinal Products for Human Use; DAS28; 28-j
Identification of UBact, a ubiquitin-like protein, along with other homologous components of a conjugation system and the proteasome in different gram-negative bacteria
Keywords: UBact; Ubiquitin; Pup; Proteasome; Bacteria; Dop; Deamidase of Pup; Mpa; mycobacterial proteasome ATPase; PafA; Proteasome accessory factor A; PPS; Pup-proteasome system; PrcA; proteasome subunit α; PrcB; proteasome subunit β; Pup; prokaryotic ubiquitin
Analysis of phenolic compounds in Greek plants of Lamiaceae family by HPLC
Keywords: API; apigenin; CA; caffeic acid; CAR; carvacrol; CAT; (+)-catechin; CIN; trans-cinnamic acid; CLA; chlorogenic acid; EPI; (â)-epicatechin; EPIG; (â)-epigallocatechine; FA; ferulic acid; GA; gallic acid; 4-HBA; 4-hydroxybenzoic acid; KAM; kaempferol; L
Improved analysis of TCRγδ variable region expression in humans
Keywords: PRCA; Pure red cell aplasia; mAbs; Monoclonal antibodies; PBMCs; Peripheral blood mononuclear cells; V region; Variable region; KIRs; Killer inhibitory receptors; γδ Τ cells; Spectratyping; Thymoma; Oligoclonal; Polyclonal; Naive;
Detection of neutralizing antibodies to erythropoietin by inhibition of rHuEPO-stimulated EGR1 gene expression in the UT-7/EPO cell line
Keywords: EPO; erythropoietin; IFN; interferon; IL-3; interleukin-3; NAb; neutralizing antibodies; PNHS; pooled normal human sera; PRCA; pure red cell aplasia; rHuEPO; recombinant human erythropoietin; Erythropoietin; Neutralizing antibodies; EGR1; Pure red cell ap
Efficacy and Long-Term Outcome of Treatment for Pure Red Cell Aplasia after Allogeneic Stem Cell Transplantation from Major ABO-Incompatible Donors
Keywords: Major ABO-mismatched HSCT; PRCA; Long-term outcome
Development and validation of an HPLC-method for determination of free and bound phenolic acids in cereals after solid-phase extraction
Keywords: IS; internal standard; LOD; limits of detection; LOQ; limits of quantification; SPE; solid-phase extraction; GA; gallic acid; PRCA; protocatechuic acid; 4-OHBA; 4-hydroxybenzoic acid; VA; vanillic acid; CA; caffeic acid; SRA; syringic acid; p-CA; p-coumar
The development and validation of a sensitive, dual-flow cell, SPR-based biosensor immunoassay for the detection, semi-quantitation, and characterization of antibodies to darbepoetin alfa and epoetin alfa in human serum
Keywords: Antibody; SPR; Biosensor immunoassay; Epoetin alfa; ESA; PRCA
Computed tomography of renal cell carcinoma in patients with terminal renal impairment
Keywords: Tx; renal allograft transplantation; CRCC; conventional renal cell carcinoma; PRCC; papillary renal cell carcinoma; PRCA; papillary renal cell adenoma; Computed tomography; Renal impairment; Hemodialysis; Kidney; Renal cell carcinoma;
Immunogenicity of therapeutic proteins. Part 3: Impact of manufacturing changes
Keywords: Biopharmaceutical; Therapeutic protein; Biosimilar; Immunogenicity; Manufacturing changes; Epoetin; PRCA
Immunogenicity of therapeutic proteins. Part 2: Impact of container closures
Keywords: Biopharmaceutical; Therapeutic protein; Biosimilar; Immunogenicity; Container closures; Epoetin; PRCA
Immunogenicity of therapeutic proteins. Part 1: Impact of product handling
Keywords: Biopharmaceutical; Therapeutic protein; Biosimilar; Immunogenicity; Neutralizing antibody; Epoetin; PRCA
Pure red cell aplasia in B-cell lymphoproliferative disorder treated with rituximab: Report of two cases and review of the literature
Keywords: PRCA; Rituximab; Anemia; Non-Hodgkin lymphoma
Chronic Lymphocytic Leukemia: Diagnosis and Treatment
Keywords: AIHA; autoimmune hemolytic anemia; AML; acute myeloid leukemia; CALGB; Cancer and Leukemia Group B; CAP; cyclophosphamide, doxorubicin (Adriamycin), and prednisone; CHOP; cyclophosphamide, hydroxydaunomycin (doxorubicin), vincristine (Oncovin) and prednis
Clinical characteristics of erythropoietin-associated pure red cell aplasia
Keywords: PRCA; epoetin; autoantibodies;
Incidence of recombinant erythropoietin (EPO) hyporesponse, EPO-associated antibodies, and pure red cell aplasia in dialysis patients
Keywords: PRCA; recombinant erythropoietin; EPO antibodies; EPO hyporesponse;